Cryptocurrencies
Eli Lilly stock swings after FDA liver failure report for GLP-1 drug
Eli Lilly (LLY) stock initially sold off on Monday morning, May 4, after the FDA disclosed a liver failure report tied to the company’s new oral obesity drug Foundayo, but shares recovered as analysts argued Read more…